A laboratory workshop and symposium was held in Turkey this past December, and, with that event, the Global Alliance for Progress (GAP) program led by the World Federation of Hemophilia (WFH) was successfully completed in the country. The GAP program has provided targeted support for multi-disciplinary medical training for a number of Hemophilia Treatment Centres in Turkey—and therefore, to the people who can impact the bleeding disorders community there, like nurses, psychosocial specialists, dentists and laboratory clinicians.
Held from December 14 to 15, 2018, at the Istanbul Medical University laboratory, the workshop was organized in cooperation with the Medical University of Istanbul Comprehensive Hemophilia Care Centre and the Hemophilia Society of Turkey. The practical hands-on training brought together more than 40 laboratory specialists from all major hemophilia labs in Turkey.
The event covered advanced training on inhibitor testing; the interpretation of mixing tests; the methodology of coagulation tests; and the clinical and laboratory aspects of von Willebrand Disease diagnosis.
The WFH would like to extend its sincere gratitude to the dedicated work of the members of the Hemophilia Society of Turkey and the medical team at the Medical University of Istanbul Comprehensive Hemophilia Care Centre. Their valuable contributions were instrumental to the success of the GAP Program in Turkey.
The GAP Program is supported by funding from: Bayer, Biotest, CSL Behring, Kedrion, Pfizer, Sanofi Genzyme, Shire, and SOBI. The WFH would also like to thank the World Health Organization for its support of the Program.